Platelet transfusion in the neonatal intensive care unit: Benefits, risks, alternatives

Neonatology

Volumn 100, Issue 3, 2011, Pages 311-318

  Christensen, Robert D ^a,b  

^a PRIMARY CHILDREN'S MEDICAL CENTER   (United States)

^b McKay Dee Hospital Center   (United States)

Author keywords

Mean platelet volume; Neonatal intensive care unit; Platelets; Practice guidelines; Reference range; Thrombocytopenia; Transfusion

Indexed keywords

ELTROMBOPAG; RECOMBINANT THROMBOPOIETIN; ROMIPLOSTIM;

APLASTIC ANEMIA; BLEEDING; BLOOD BANK; CANCER MORTALITY; COST CONTROL; DRUG SAFETY; HEALTH CARE COST; HUMAN; LEUKEMIA; NEWBORN INTENSIVE CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTE VOLUME; THROMBOCYTOPENIA;

HUMANS; INFANT, NEWBORN; INTENSIVE CARE UNITS, NEONATAL; PLATELET COUNT; PLATELET TRANSFUSION; PRACTICE GUIDELINES AS TOPIC; REFERENCE VALUES; RISK ASSESSMENT; THROMBOCYTOPENIA;

EID: 84859066659     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000329925     Document Type: Review

References (42)

1. Roberts I, Stanworth S, Murray NA: Thrombocytopenia inthe neonate. Blood Rev 2008;22:173-186.
2. Ferrer-Marin F, Liu ZJ, Gutti R, Sola-Visner M: Neonatal thrombocytopenia and megakaryocytopoiesis. Semin Hematol 2010;47:281-288.
3. Wiedmeier SE, Henry E, Sola-Visner MC, Christensen RD: Platelet reference ranges for neonates, defined using data from over 47,000 patients in a multihospital healthcare system. J Perinatol 2009;29:130-136.
4. Murray NA, Watts TL, Roberts IA: Thrombopoietin in the fetus and neonate. Early Hum Dev 2000;59:1-12.
5. Sola MC, Calhoun DA, Hutson AD, Christensen RD: Plasma thrombopoietin concentrations in thrombocytopenic and nonthrombocytopenic patients in a neonatal intensive care unit. Br J Haematol 1999;104:90-92. (Pubitemid 29037023)
6. Kline A, Mackley A, Taylor SM, McKenzie SE, Paul DA: Thrombopoietin following transfusion of platelets in preterm neonates. Platelets 2008;19:428-431.
7. Jensen J, Wiedmeier SE, Henry E, Silver RM, Christensen RD: Linking maternal platelet counts with neonatal platelet counts and outcomes using the data repositories of a multihospital healthcare system. Am J Perinatol 2011, E-pub ahead of print.
8. Christensen RD, Henry E, Wiedmeier SE, Stoddard RA, Sola-Visner MC, Lambert DK, Kiehn TI, Ainsworth S: Thrombocytopenia among extremely low birth weight neonates: data from a multihospital healthcare system. J Perinatol 2006;26:348-353. (Pubitemid 43811510)
9. Baer VL, Lambert DK, Henry E, Christensen RD: Severe thrombocytopenia in the NICU. Pediatrics 2009;124:e1095-e1100.
10. Stanworth SJ, Clarke P, Watts T, Ballard S, Choo L, Morris T, Murphy MF, Roberts I, Platelets and Neonatal Transfusion Study Group: Prospective, observational study of outcomes in neonates with severe thrombocytopenia. Pediatrics 2009;124:e826-e834.
11. Hu A, Slayton WB, Rimsza LM, Bailey M, Sallmon H, Sola-Visner MC: Differences between newborn and adult mice in their response to immune thrombocytopenia. Neonatology 2010;98:100-108.
12. Bussel JB, Sola-Visner M: Current approaches to the evaluation and management of the fetus and neonate with immune thrombocytopenia. Semin Perinatol 2009;33:35-42.
13. Bussel JB, Primiani A: Fetal and neonatal alloimmune thrombocytopenia: progress and ongoing debates. Blood Rev 2008;22:33-52. (Pubitemid 351193026)
14. Murphy MF, Bussel JB: Advances inthe management of alloimmune thrombocytopenia. Br J Haematol 2007;136:366-378. (Pubitemid 46046295)
15. Baer VL, Lambert DK, Henry E, Snow GL, Butler A, Christensen RD: Among very-low-birth-weight neonates is red blood cell transfusion an independent risk factor for subsequently developing a severe intraventricular hemorrhage? Transfusion 2011;51:1170-1178.
16. Baer VL, Lambert DK, Henry E, Snow GL, Christensen RD: Red blood cell transfusion of preterm neonates with a grade 1 intraventricular hemorrhage is associated with extension to a grade 3 or 4 hemorrhage. Transfusion 2011 DOI: 10.1111/j.1537-2995.2011. 03081.x.
17. Saxonhouse MA, Manco-Johnson MJ: The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009;33:52-65.
18. Andrew M, Vegh P, Caco C, Kirpalani H, Jefferies A, Ohlsson A, Watts J, Saigal S, Milner R, Wang E: A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants. J Pediatr 1993;123:285-291. (Pubitemid 23221114)
19. von Lindern JS, van den Bruele T, Lopriore E, Walther FJ: Thrombocytopenia inneonates and the risk of intraventricular hemorrhage: a retrospective cohort study. BMC Pediatr 2011;11:16.
20. Dohner ML, Wiedmeier SE, Stoddard RA, Null D Jr, Lambert DK, Burnett J, Baer VL, Hunt JC, Henry E, Christensen RD: Very high users of platelet transfusions in the neonatal intensive care unit. Transfusion 2009;49:869-872.
21. Murray NA, Howarth LJ, McCloy MP, Letsky EA, Roberts IA: Platelet transfusion in the management of severe thrombocytopenia in neonatal intensive care unit patients. Transfus Med 2002;12:35-41. (Pubitemid 34184944)
22. Calhoun DA, Christensen RD, Edstrom CS, Juul SE, Ohls RK, Schibler KR, Sola MC, Sullivan SE: Consistent approaches to procedures and practices in neonatal hematology. Clin Perinatol 2000;27:733-753.
23. Gerday E, Baer VL, Lambert DK, Paul DA, Sola-Visner MC, Pysher TJ, Christensen RD: Testing platelet mass versus platelet count to guide platelet transfusions in the neonatal intensive care unit. Transfusion 2009;49:2034-2039.
24. Estcourt LJ, Stanworth SJ, Murphy MF: Prophylactic platelet transfusions. Curr Opin Hematol 2010;17:411-417.
25. Saxonhouse MA, Garner R, Mammel L, Li Q, Muller KE, Greywoode J, Miller C, Sola- Visner M:Closure times measured by the platelet function analyzer PFA-100 are longer in neonatal blood compared with cord blood samples. Neonatology 2010;97:242-249.
26. Corazza MS, Davis RF, Merritt TA, Bejar R, Cvetnic W: Prolonged bleeding time in preterm infants receiving indomethacin for patent ductus arteriosus. J Pediatr 1984;105:292-296. (Pubitemid 14060228)
27. Sheffield MJ, Schmutz N, Lambert DK, Henry E, Christensen RD: Ibuprofen lysine administration to neonates with a patent ductus arteriosus: effect on platelet plug formation assessed by in vivo and in vitro measurements. J Perinatol 2009;29:39-43.
28. Sheffield MJ, Lambert DK, Henry E, Christensen RD: Effect of ampicillin on the bleeding time of neonatal intensive care unit patients. J Perinatol 2010;30:527-530.
29. Sheffield MJ, Lambert DK, Baer VL, Henry E, Butler A, Snow GL, Christensen RD: Effect of ampicillin on bleeding time in very low birth-weight neonates during the first week after birth. J Perinatol 2011, E-pub ahead of print.
30. George TN, Johnson KJ, Bates JN, Segar JL: The effect of inhaled nitric oxide therapy on bleeding time and platelet aggregation in neonates. J Pediatr 1998;132:731-734. (Pubitemid 28194601)
31. Christensen RD, Sheffield MJ, Lambert DK, Baer VL: Effect of therapeutic hypothermia on platelet function in neonates with hypoxic-ischemic encephalopathy. Neonatology, in press.
32. Petäjä J, Andersson S, Syrjälä M: A simple automatized audit system for following and managing practices of platelet and plasma transfusions in a neonatal intensive care unit. Transfus Med 2004;14:281-288.
33. Baer VL, Lambert DK, Schmutz N, Henry E, Stoddard RA, Miner C, Wiedmeier SE, Burnett J, Eggert LD, Christensen RD: Adherence to NICU transfusion guidelines: data from a multihospital healthcare system. J Perinatol 2008;28:492-497. (Pubitemid 351973992)
34. Baer VL, Henry E, Lambert DK, Stoddard RA, Wiedmeier SE, Eggert LD, Ilstrup S, Christensen RD: Implementing a program to improve compliance with neonatal intensive care unit transfusion guidelines was accompanied by a reduction in transfusion rate: a pre-post analysis within a multihospital health care system. Transfusion 2011;51:264-269.
35. Rood IG, de Korte D, Ramirez-Arcos S, Savelkoul PH, Pettersson A: Distribution, origin and risk of coagulase-negative staphylococci from platelet concentrates. J Med Microbiol 2011;60:592-599.
36. Baer VL, Lambert DK, Henry E, Snow GL, Sola-Visner MC, Christensen RD: Do platelet transfusions inthe NICU adversely affect survival? Analysis of 1,600 thrombocytopenic neonates in a multihospital healthcare system. J Perinatol 2007;27:790-796. (Pubitemid 350176961)
37. Garcia MG, Duenas E, Sola MC, Hutson AD, Theriaque D, Christensen RD: Epidemiologic and outcome studies of patients who received platelet transfusions in the neonatal intensive care unit. J Perinatol 2001;21:415-420. (Pubitemid 32976172)
38. Del Vecchio A, Sola MC, Theriaque DW, Hutson AD, Kao KJ, Wright D, Garcia MG, Pollock BH, Christensen RD: Platelet transfusions inthe neonatal intensive care unit: factors predicting which patients will require multiple transfusions. Transfusion 2001;41:803-808. (Pubitemid 32538518)
39. Josephson CD, Su LL, Christensen RD, Hillyer CD, Castillejo MI, Emory MR, Lin Y, Hume H, Easley K, Poterjoy B, Sola-Visner M: Platelet transfusion practices among neonatologists in the United States and Canada: results of a survey. Pediatrics 2009;123:278-285.
40. Del Vecchio A, Latini G, Henry E, Christensen RD: Template bleeding times of 240 neonates born at 24 to 41 weeks gestation. J Perinatol 2008;28:427-431. (Pubitemid 351780937)
41. Sallmon H, Gutti RK, Ferrer-Marin F, Liu ZJ, Sola-Visner MC: Increasing platelets without transfusion: is it time to introduce novel thrombopoietic agents in neonatal care? J Perinatol 2010;30:765-769.
42. Blajchman MA, Glynn SA, Josephson CD, Kleinman SH, State-of-the-Science Symposium Transfusion Medicine Committee: Clinical trial opportunities in transfusion medicine: proceedings of a National Heart, Lung, and Blood Institute State-of-the-Science Symposium. Transfus Med Rev 2010;24:259-285.